A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis

BACKGROUND: Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on public health, and are responsible for thousands of deaths each year. C...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Santiso, Rebeca, Tamayo, María, Gosálvez, Jaime, Bou, Germán, Fernández, María del Carmen, Fernández, José Luis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2011
Gaiak:
Methodology Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3179955/
https://ncbi.nlm.nih.gov/pubmed/21867549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2180-11-191
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak